Log In
CQMS
Make a Donation
Log In
Donate
DONATE OR FUNDRAISE
Donate
Read Angelo's story about taking part in our kidney cancer trial
Sign up now to join our fun Km's for Cancer Research Challenge
Meet our new TSC Chair-Elect and members
Submit your abstract for our 2027 Annual Scientific Meeting, Hobart, 9-12 March 2027.
TROG receives $2.86m MRFF grant for new breast cancer trial

TROG 02.03 – BLADDER (Phase III)

Closed
Bladder, Kidney & Prostate

Randomised phase III trial of radical chemo/radiotherapy vs radiotherapy alone in the definitive management of localised muscle invasive TCC of the urinary bladder

Primary Sponsor

Urological Society of Australasia

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Final Accrual

67

Trial Chairperson

Dr Kumar Gogna, QRI Mater Centre, QLD

Trial Contact

Kumar Gogna

Clinical Trial Registration

Registration Link

Prev Post

TROG 03.01 – Oesophagus

Next Post

TROG 11.A – ANROTAT

Related Post

29 July, 2026

TROG to run breast cancer trial in Australia after gaining $2.86m grant

LATEST NEWS: 29 July 2026 TROG Cancer Research is

new TROG Scientific Committee Chair Elect and members
21 July, 2026

New TROG Scientific Committee Chair-Elect and members bring diverse experience

LATEST NEWS: 21 July 2026 The TROG Scientific Committee